Concepts (40)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 1 | 2025 | 448 | 0.770 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family | 2 | 2020 | 4 | 0.320 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2025 | 140 | 0.220 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2025 | 132 | 0.220 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 686 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4757 | 0.170 |
Why?
|
| Apoptosis | 1 | 2025 | 1899 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 241 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2025 | 4710 | 0.130 |
Why?
|
| Interferon-alpha | 1 | 2018 | 246 | 0.130 |
Why?
|
| Neutrophils | 1 | 2018 | 360 | 0.130 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 450 | 0.120 |
Why?
|
| HIV-1 | 1 | 2018 | 484 | 0.110 |
Why?
|
| Melanoma | 1 | 2020 | 952 | 0.100 |
Why?
|
| Mice | 3 | 2025 | 18478 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 896 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1754 | 0.090 |
Why?
|
| Animals | 3 | 2025 | 34804 | 0.080 |
Why?
|
| HIV Infections | 1 | 2018 | 2047 | 0.060 |
Why?
|
| Immunomodulation | 1 | 2024 | 78 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3043 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 38 | 0.040 |
Why?
|
| Humans | 4 | 2025 | 132064 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 218 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2020 | 153 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 127 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 2018 | 16 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2018 | 31 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2024 | 550 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2018 | 53 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 293 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2020 | 1572 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3682 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 879 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 2057 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3865 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2227 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 4527 | 0.020 |
Why?
|
| Female | 2 | 2024 | 70664 | 0.010 |
Why?
|
| Male | 1 | 2020 | 64938 | 0.010 |
Why?
|